Omega Flex Inc (OFLX)
66.26
-1.22
(-1.81%)
USD |
NASDAQ |
Apr 30, 16:00
66.50
+0.24
(+0.35%)
After-Hours: 20:00
Omega Flex Research and Development Expense (Quarterly): 1.014M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.014M |
| September 30, 2023 | 0.992M |
| June 30, 2023 | 0.907M |
| March 31, 2023 | 0.955M |
| December 31, 2022 | 1.219M |
| September 30, 2022 | 1.101M |
| June 30, 2022 | 1.197M |
| March 31, 2022 | 1.216M |
| December 31, 2021 | 1.284M |
| September 30, 2021 | 1.113M |
| June 30, 2021 | 1.212M |
| March 31, 2021 | 1.001M |
| December 31, 2020 | 1.114M |
| September 30, 2020 | 0.945M |
| June 30, 2020 | 1.021M |
| March 31, 2020 | 1.12M |
| December 31, 2019 | 1.06M |
| September 30, 2019 | 1.162M |
| June 30, 2019 | 1.152M |
| March 31, 2019 | 1.341M |
| December 31, 2018 | 1.452M |
| September 30, 2018 | 1.221M |
| June 30, 2018 | 1.11M |
| March 31, 2018 | 1.03M |
| December 31, 2017 | 0.825M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.798M |
| June 30, 2017 | 0.862M |
| March 31, 2017 | 0.808M |
| December 31, 2016 | 0.886M |
| September 30, 2016 | 0.808M |
| June 30, 2016 | 0.779M |
| March 31, 2016 | 0.712M |
| December 31, 2015 | 0.643M |
| September 30, 2015 | 0.69M |
| June 30, 2015 | 0.72M |
| March 31, 2015 | 0.631M |
| December 31, 2014 | 0.795M |
| September 30, 2014 | 0.764M |
| June 30, 2014 | 0.658M |
| March 31, 2014 | 0.704M |
| December 31, 2013 | 0.741M |
| September 30, 2013 | 0.673M |
| June 30, 2013 | 0.626M |
| March 31, 2013 | 0.718M |
| December 31, 2012 | 0.667M |
| September 30, 2012 | 0.70M |
| June 30, 2012 | 0.595M |
| March 31, 2012 | 0.635M |
| December 31, 2011 | 0.614M |
| September 30, 2011 | 0.618M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.907M
Minimum
Jun 2023
1.284M
Maximum
Dec 2021
1.094M
Average
1.113M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Gorman-Rupp Co | -- |
| Xylem Inc | 60.00M |
| Ault Alliance Inc | 1.819M |
| Smith & Wesson Brands Inc | 1.969M |
| Axon Enterprise Inc | 83.97M |